Your browser doesn't support javascript.
loading
Obesity Is Associated with Altered Tumor Metabolism in Metastatic Melanoma.
Hahn, Andrew W; Menk, Ashley V; Rivadeneira, Dayana B; Augustin, Ryan C; Xu, Mingchu; Li, Jun; Wu, Xiaogang; Mishra, Aditya K; Gide, Tuba N; Quek, Camelia; Zang, Yan; Spencer, Christine N; Menzies, Alexander M; Daniel, Carrie R; Hudgens, Courtney W; Nowicki, Theodore; Haydu, Lauren E; Khan, M A Wadud; Gopalakrishnan, Vancheswaran; Burton, Elizabeth M; Malke, Jared; Simon, Julie M; Bernatchez, Chantale; Putluri, Nagireddy; Woodman, Scott E; Vashisht Gopal, Y N; Guerrieri, Renato; Fischer, Grant M; Wang, Jian; Wani, Khalida M; Thompson, John F; Lee, Jeffrey E; Hwu, Patrick; Ajami, Nadim; Gershenwald, Jeffrey E; Long, Georgina V; Scolyer, Richard A; Tetzlaff, Michael T; Lazar, Alexander J; Schadendorf, Dirk; Wargo, Jennifer A; Kirkwood, John M; DeBerardinis, Ralph J; Liang, Han; Futreal, Andrew; Zhang, Jianhua; Wilmott, James S; Peng, Weiyi; Davies, Michael A; Delgoffe, Greg M.
Afiliação
  • Hahn AW; Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Menk AV; Department of Immunology, University of Pittsburgh, Pittsburgh, Pennsylvania.
  • Rivadeneira DB; Department of Immunology, University of Pittsburgh, Pittsburgh, Pennsylvania.
  • Augustin RC; Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania.
  • Xu M; Department of Genomic Medicine, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Li J; Department of Bioinformatics and Computational Biology, Division of Basic Sciences, University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Wu X; Department of Genomic Medicine, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Mishra AK; Department of Genomic Medicine, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Gide TN; Melanoma Institute of Australia, The University of Sydney, Sydney, New South Wales, Australia.
  • Quek C; Melanoma Institute of Australia, The University of Sydney, Sydney, New South Wales, Australia.
  • Zang Y; Department of Immunology, University of Pittsburgh, Pittsburgh, Pennsylvania.
  • Spencer CN; Parker Institute for Cancer Immunotherapy, San Francisco, California.
  • Menzies AM; Melanoma Institute of Australia, The University of Sydney, Sydney, New South Wales, Australia.
  • Daniel CR; Department of Epidemiology, Division of Cancer Prevention and Population Sciences, University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Hudgens CW; Department of Translational Molecular Pathology, Division of Pathology and Laboratory Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Nowicki T; Division of Pediatric Hematology-Oncology, Department of Pediatrics, University of California Los Angeles, Los Angeles, California.
  • Haydu LE; Jonsson Comprehensive Cancer Center, University of California Los Angeles, Los Angeles, California.
  • Khan MAW; Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research, University of California Los Angeles, Los Angeles, California.
  • Gopalakrishnan V; Department of Surgical Oncology, Division of Surgery, University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Burton EM; Department of Surgical Oncology, Division of Surgery, University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Malke J; Department of Surgical Oncology, Division of Surgery, University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Simon JM; Department of Genomic Medicine, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Bernatchez C; Department of Surgical Oncology, Division of Surgery, University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Putluri N; Department of Surgical Oncology, Division of Surgery, University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Woodman SE; Department of Biologics Development, Division of Therapeutics Discovery, University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Vashisht Gopal YN; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas.
  • Guerrieri R; Department of Genomic Medicine, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Fischer GM; Department of Melanoma Medical Oncology, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Wang J; Department of Melanoma Medical Oncology, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Wani KM; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.
  • Thompson JF; Department of Biostatistics, Division of Biosciences, University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Lee JE; Department of Translational Molecular Pathology, Division of Pathology and Laboratory Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Hwu P; Melanoma Institute of Australia, The University of Sydney, Sydney, New South Wales, Australia.
  • Ajami N; Department of Surgical Oncology, Division of Surgery, University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Gershenwald JE; Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa Bay, Florida.
  • Long GV; Department of Genomic Medicine, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Scolyer RA; Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research, University of California Los Angeles, Los Angeles, California.
  • Tetzlaff MT; Melanoma Institute of Australia, The University of Sydney, Sydney, New South Wales, Australia.
  • Lazar AJ; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.
  • Schadendorf D; Charles Perkins Centre, The University of Sydney, Sydney, New South Wales, Australia.
  • Wargo JA; Melanoma Institute of Australia, The University of Sydney, Sydney, New South Wales, Australia.
  • Kirkwood JM; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.
  • DeBerardinis RJ; Charles Perkins Centre, The University of Sydney, Sydney, New South Wales, Australia.
  • Liang H; Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital and NSW Health Pathology, Sydney, New South Wales, Australia.
  • Futreal A; Division of Dermatopathology, Department of Pathology, University of California San Francisco, San Francisco, California.
  • Zhang J; Department of Genomic Medicine, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Wilmott JS; Department of Translational Molecular Pathology, Division of Pathology and Laboratory Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Peng W; Department of Dermatology, Venereology, and Allergology, University Hospital Essen and German Cancer Consortium, Partner site Essen, Germany.
  • Davies MA; Department of Genomic Medicine, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Delgoffe GM; Department of Surgical Oncology, Division of Surgery, University of Texas MD Anderson Cancer Center, Houston, Texas.
Clin Cancer Res ; 29(1): 154-164, 2023 01 04.
Article em En | MEDLINE | ID: mdl-36166093
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Segunda Neoplasia Primária / Melanoma Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Revista: Clin Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Segunda Neoplasia Primária / Melanoma Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Revista: Clin Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article